Literature DB >> 12089422

Therapies. Confronting the limits of success.

Jon Cohen.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12089422     DOI： 10.1126/science.296.5577.2320

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  11 in total

1.  Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors.

Authors:  Lindsey Reynolds; Christopher Ullman; Michael Moore; Mark Isalan; Michelle J West; Paul Clapham; Aaron Klug; Yen Choo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

2.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

Review 3.  Pathogenesis of HIV in the gastrointestinal tract.

Authors:  Satya Dandekar
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

4.  Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.

Authors:  Moraima Guadalupe; Sumathi Sankaran; Michael D George; Elizabeth Reay; David Verhoeven; Barbara L Shacklett; Jason Flamm; Jacob Wegelin; Thomas Prindiville; Satya Dandekar
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.

Authors:  Roberto Di Santo; Roberta Costi; Alessandra Roux; Marino Artico; Antonio Lavecchia; Luciana Marinelli; Ettore Novellino; Lucia Palmisano; Mauro Andreotti; Roberta Amici; Clementina Maria Galluzzo; Lucia Nencioni; Anna Teresa Palamara; Yves Pommier; Christophe Marchand
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

6.  Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. fusion [corrected] inhibition.

Authors:  Sylvia Lee-Huang; Philip Lin Huang; Dawei Zhang; Jae Wook Lee; Ju Bao; Yongtao Sun; Young-Tae Chang; John Zhang; Paul Lee Huang
Journal:  Biochem Biophys Res Commun       Date:  2007-01-24       Impact factor: 3.575

7.  Molecular dynamics studies of the transmembrane domain of gp41 from HIV-1.

Authors:  Jong Hwa Kim; Taryn L Hartley; A Rachael Curran; Donald M Engelman
Journal:  Biochim Biophys Acta       Date:  2009-06-21

8.  Inhibiting the HIV integration process: past, present, and the future.

Authors:  Roberto Di Santo
Journal:  J Med Chem       Date:  2013-09-25       Impact factor: 7.446

9.  Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.

Authors:  Roberto Di Santo; Roberta Costi; Alessandra Roux; Gaetano Miele; Giuliana Cuzzucoli Crucitti; Alberto Iacovo; Federica Rosi; Antonio Lavecchia; Luciana Marinelli; Carmen Di Giovanni; Ettore Novellino; Lucia Palmisano; Mauro Andreotti; Roberta Amici; Clementina Maria Galluzzo; Lucia Nencioni; Anna Teresa Palamara; Yves Pommier; Christophe Marchand
Journal:  J Med Chem       Date:  2008-07-23       Impact factor: 7.446

10.  HIV-1 and Human PEG10 Frameshift Elements Are Functionally Distinct and Distinguished by Novel Small Molecule Modulators.

Authors:  Tony S Cardno; Yosuke Shimaki; Brad E Sleebs; Kurt Lackovic; John P Parisot; Rebecca M Moss; Caillan Crowe-McAuliffe; Suneeth F Mathew; Christina D Edgar; Torsten Kleffmann; Warren P Tate
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.